Pfizer: Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Half YearEnded September 30 2025

Pursuant to Regulations 30 and 33 of the Listing Regulations we submit herewith the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025 which were inter alia approved by the Board of Directors of the Company at their Meeting held today i.e. November 12 2025 that commenced at 2.00 p.m. and concluded at 3.15 p.m.